BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 424702)

  • 1. Effect of calcium and factor D depletion on C3 conversion by rat intestinal glycoprotein.
    Winsnes R
    Scand J Immunol; 1979; 9(2):135-40. PubMed ID: 424702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement (C3) conversion by rat intestinal glycoprotein and its degradation products.
    Winsnes R
    Scand J Immunol; 1980; 12(1):67-76. PubMed ID: 6997988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of factor D of the alternative complement pathway.
    Lesavre PH; Müller-Eberhard HJ
    J Exp Med; 1978 Dec; 148(6):1498-509. PubMed ID: 82604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal glycoprotein activates the alternative complement pathway by reacting with factor H.
    Winsnes R; Lachmann PJ
    Scand J Immunol; 1982 Apr; 15(4):371-8. PubMed ID: 6213029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro inhibition of the classical pathway of human complement by a natural microbial product, colistin sulphate.
    Asghar SS; de Koster A; van der Helm HJ
    Biochem Pharmacol; 1986 Sep; 35(17):2917-21. PubMed ID: 3638137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
    Inada K
    Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the classical complement pathway by BioRex-70.
    Vandenberg RJ; Easterbrook-Smith SB
    Immunol Lett; 1987 Jan; 14(2):155-8. PubMed ID: 3495488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of complement activity in turkeys: evidence for classical and alternative complement pathways.
    Ellis MG; Lamont SJ; Arp LH
    Poult Sci; 1989 May; 68(5):646-50. PubMed ID: 2666975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A one-step procedure for preparation of classical pathway (C1q) and alternative pathway (factor D) depleted human serum.
    Praz F; Roque Antunes Barreira MC; Lesavre P
    J Immunol Methods; 1982; 50(2):227-31. PubMed ID: 7045233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of complement by gold sodium thiomalate.
    Hasselbacher P
    J Rheumatol; 1981; 8(1):57-61. PubMed ID: 6783754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV; Shibanova ED; Zinchenko AA
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirements for the solubilization of immune aggregates by complement. The role of the classical pathway.
    Takahashi M; Takahashi S; Brade V; Nussenzweig V
    J Clin Invest; 1978 Aug; 62(2):349-58. PubMed ID: 670397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the alternative and classical complement pathways by Entamoeba histolytica.
    Calderon J; Schreiber RD
    Infect Immun; 1985 Nov; 50(2):560-5. PubMed ID: 2865212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proteases in complement system (author's transl)].
    Nagasawa S
    Tanpakushitsu Kakusan Koso; 1980; 25(6):531-46. PubMed ID: 7010425
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of carrageenan in complement activation.
    Baker KC; Nicklin S; Miller K
    Food Chem Toxicol; 1986 Sep; 24(9):891-5. PubMed ID: 3096850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a streptococcal preparation on the complement system.
    Kato H; Yokoe N; Matsumura N; Nishida K; Ikezaki M; Hosokawa K; Hotta T; Takemura S; Yoshikawa T; Kondo M
    Jpn J Exp Med; 1979 Oct; 49(5):343-50. PubMed ID: 529490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor J, an inhibitor of the classical and alternative complement pathway, does not inhibit esterolysis by factor D.
    González-Rubio C; González-Muñiz R; Jiménez-Clavero MA; Fontán G; López-Trascasa M
    Biochim Biophys Acta; 1996 Jul; 1295(2):174-8. PubMed ID: 8695643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanosoma lewisi: restriction of alternative complement pathway C3/C5 convertase activity.
    Sturtevant JE; Balber AE
    Exp Parasitol; 1987 Jun; 63(3):260-71. PubMed ID: 3556206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between the alternative complement pathway and proteases of the coagulation system.
    Kazatchkine MD; Jouvin MH
    Adv Exp Med Biol; 1984; 167():235-9. PubMed ID: 6561912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.